16 research outputs found
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus
BACKGROUND: Previous studies by our group suggest that extracellular dopamine (DA) and noradrenaline (NA) may be co-released from noradrenergic nerve terminals in the cerebral cortex. We recently demonstrated that the concomitant release of DA and NA could be elicited in the cerebral cortex by electrical stimulation of the locus coeruleus (LC). This study analyses the effect of both single train and repeated electrical stimulation of LC on NA and DA release in the medial prefrontal cortex (mPFC), occipital cortex (Occ), and caudate nucleus. To rule out possible stressful effects of electrical stimulation, experiments were performed on chloral hydrate anaesthetised rats. RESULTS: Twenty min electrical stimulation of the LC, with burst type pattern of pulses, increased NA and DA both in the mPFC and in the Occ. NA in both cortices and DA in the mPFC returned to baseline within 20 min after the end of the stimulation period, while DA in the Occ reached a maximum increase during 20 min post-stimulation and remained higher than baseline values at 220 min post-stimulation. Local perfusion with tetrodotoxin (TTX, 10 μM) markedly reduced baseline NA and DA in the mPFC and Occ and totally suppressed the effect of electrical stimulation in both areas. A sequence of five 20 min stimulations at 20 min intervals were delivered to the LC. Each stimulus increased NA to the same extent and duration as the first stimulus, whereas DA remained elevated at the time next stimulus was delivered, so that baseline DA progressively increased in the mPFC and Occ to reach about 130 and 200% the initial level, respectively. In the presence of the NA transport (NAT) blocker desipramine (DMI, 100 μM), multiple LC stimulation still increased extracellular NA and DA levels. Electrical stimulation of the LC increased NA levels in the homolateral caudate nucleus, but failed to modify DA level. CONCLUSION: The results confirm and extend that LC stimulation induces a concomitant release of DA and NA in the mPFC and Occ. The different time-course of LC-induced elevation of DA and NA suggests that their co-release may be differentially controlled
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
Dynamin 1 is required for memory formation.
Dynamin 1-3 isoforms are known to be involved in endocytotic processes occurring during synaptic transmission. No data has directly linked dynamins yet with normal animal behavior. Here we show that dynamin pharmacologic inhibition markedly impairs hippocampal-dependent associative memory. Memory loss was associated with changes in synaptic function occurring during repetitive stimulation that is thought to be linked with memory induction. Synaptic fatigue was accentuated by dynamin inhibition. Moreover, dynamin inhibition markedly reduced long-term potentiation, post-tetanic potentiation, and neurotransmitter released during repetitive stimulation. Most importantly, the effect of dynamin inhibition onto memory and synaptic plasticity was due to a specific involvement of the dynamin 1 isoform, as demonstrated through a genetic approach with siRNA against this isoform to temporally block it. Taken together, these findings identify dynamin 1 as a key protein for modulation of memory and release evoked by repetitive activity
Dynamin inhibition by dynasore increases synaptic fatigue following sustained activity in hippocampus.
<p><b>A</b>, Dynasore treatment (80 μM, open triangles) increases SF in slices that were previously treated with vehicle (black circles) (F<sub>1,12</sub> = 6.395, <i>p</i> = 0.026). The increase is already present at the 10<sup>th</sup> pulse during the stimulation (Mann-Whitney U<sub>69, 36</sub> = 8.00, <i>p</i> = 0.0379). The effect was reversed by washout with vehicle (open squares). SF was induced by high frequency stimulation in the presence of D-APV (100 μM). <b>B</b>, SF was induced by high frequency stimulation (100 Hz, 1 second) in slices containing both D-APV (100 μM) and cyclothiazide (100 μM). Dynasore (80 μM, open triangles) further increases SF compared to fatigue of the same slices in the presence of vehicle (black circles) (F<sub>1,12</sub> = 6.395, <i>p</i> = 0.026). SF increases in dynasore-treated slices already at the 10<sup>th</sup> pulse during the tetanus (Mann-Whitney U<sub>35, 10</sub> = 0.0001, <i>p</i> = 0.0159). The effect is reversed by washout with vehicle (open squares), re-establishing SF to the values obtained prior to dynasore perfusion. <b>C</b>, SF is induced by high frequency stimulation (100 Hz, 1 second) in vehicle-treated slices (black circles) containing both D-APV (100 μM), the GABA<sub>A</sub> receptor blocker picrotoxin (30 μM), the GABA<sub>B</sub> receptor blocker SCH 50911 (100 μM). Dynasore (80 μM, open triangles) further increases SF compared to fatigue of the same slices in the presence of vehicle (black circles) (F<sub>1,12</sub> = 6.395, <i>p</i> = 0.026). SF increases in dynasore-treated slices already at the 10<sup>th</sup> pulse during the tetanus (Mann-Whitney U<sub>159, 94</sub> = 28.00, <i>p</i> = 0.0356). The effect is reversed by washout with vehicle (open squares), re-establishing SF to the values obtained prior to dynasore perfusion. Data shows dynasore-induced increase in SF is not associated to AMPA receptor desensitization or changes in GABA<sub>A/B</sub> responsiveness. Error bars indicate SEM.</p
Role of Amyloid-β and Tau Proteins in Alzheimer's Disease : Confuting the Amyloid Cascade
Altres ajuts: R01 AG017761/AG/NIA NIH HHS/United States; R01 AG049402/AG/NIA NIH HHS/United StatesThe "Amyloid Cascade Hypothesis" has dominated the Alzheimer's disease (AD) field in the last 25 years. It posits that the increase of amyloid-β (Aβ) is the key event in AD that triggers tau pathology followed by neuronal death and eventually, the disease. However, therapeutic approaches aimed at decreasing Aβ levels have so far failed, and tau-based clinical trials have not yet produced positive findings. This begs the question of whether the hypothesis is correct. Here we have examined literature on the role of Aβ and tau in synaptic dysfunction, memory loss, and seeding and spreading of AD, highlighting important parallelisms between the two proteins in all of these phenomena. We discuss novel findings showing binding of both Aβ and tau oligomers to amyloid-β protein precursor (AβPP), and the requirement for the presence of this protein for both Aβ and tau to enter neurons and induce abnormal synaptic function and memory. Most importantly, we propose a novel view of AD pathogenesis in which extracellular oligomers of Aβ and tau act in parallel and upstream of AβPP. Such a view will call for a reconsideration of therapeutic approaches directed against Aβ and tau, paving the way to an increased interest toward AβPP, both for understanding the pathogenesis of the disease and elaborating new therapeutic strategies
Dynamin inhibition by dynasore affects LTP, a type of synaptic plasticity due to sustained activity in hippocampus.
<p><b>A</b>, Dynasore (80 μM, 20 minute perfusion, open triangles) decreases LTP induced by theta-burst stimulation in CA<sub>3</sub>–CA<sub>1</sub> synapses compared to vehicle-treated slices (black circles)(F<sub>1,10</sub> = 9.081, <i>p</i> = 0.013). The horizontal bar indicates the period of perfusion with dynasore before tetanic stimulation. <b>B</b>, Post-tetanus dynamin inhibition by dynasore (80 μm, 20 minute perfusion <i>after</i> the tetanus delivery, open triangle) induced by theta-burst stimulation in CA<sub>3</sub>–CA<sub>1</sub> synapses compared to vehicle-treated slices (black circles; F<sub>1,7</sub> = 0.209, <i>p</i> = 0.662). The horizontal bar indicates the period of perfusion with dynasore <i>after</i> tetanic stimulation. <b>C</b>, Basal synaptic transmission is unmodified by dynamin inhibition with dynasore. Averaged evoked field potential slopes as a function of stimulation intensity measured in volts (V) at CA<sub>3</sub>–CA<sub>1</sub> synapses in slices do not show significant differences between vehicle-treated (black circles) and dynasore (80 μM, open triangles) treated slices (F<sub>1,11</sub> = 40.081, <i>p</i> = 0.7013). <b>D</b>, Dynamin inhibition by dynasore (open triangles; 80 μm, 20 minute perfusion before the tetanus) does not produce changes in solely post-synaptic LTP induced by three tetani at 50 Hz for 1 second, each tetanus separated by 20 seconds, at the CA<sub>3</sub>–CA<sub>1</sub> synapse compared to vehicle-treated slices (black circles; F1,8 = 1.538, p = 0.250). The horizontal bar indicates the period of perfusion with dynasore before tetanic stimulation. Error bars indicate SEM.</p
Selective dynamin 1 inhibition through siRNA impairs both synaptic plasticity and associative memory.
<p><b>A</b>, siRNA specific for murine dynamin 1 reduces protein expression. An example of western blot showing that Penetratin 1- conjugated dynamin 1 siRNA reduces protein expression. Cells are lysed 48 hours after the treatment with siRNA. Dynamin 1 is detected using a rabbit polyclonal anti-dynamin1 antibody. Penetratin 1- conjugated Control siRNA, that does not affect dynamin 1 expression, does not change protein levels. n = 3 for each group. <b>B</b>, Penetratin 1- conjugated dynamin 1 siRNA (open bars) (80 nM in a final volume of 1.5 μl over 1 minute, bilateral injections twice a day for 3 days) impairs contextual fear memory compared to control siRNA infused mice (grey bars) (Mann-Whitney U<sub>150, 126</sub> = 21.00, <i>p</i> = 0.0089). Moreover, control siRNA infused mice show similar amount of freezing as vehicle-infused animals (black bars). <b>C</b>, Penetratin 1- conjugated dynamin 1 siRNA (open bars) does not modify cued fear memory compared to Penetratin 1- conjugated Control siRNA (grey bars) (Mann-Whitney U<sub>99, 90</sub> = 44.50, <i>p</i> = 1.00) in mice previously tested for contextual fear conditioning at 24 hours after the shock. <b>D</b>, Bilateral infusions of Penetratin 1- conjugated dynamin 1 siRNA (open triangles) (80 nM in a final volume of 1.5 μl over 1 minute, repeated 2 times a day for three days) into dorsal hippocampi decrease LTP compared to Penetratin 1- conjugated Control siRNA treatment (grey squares) (F<sub>1,9</sub> = 5.578, <i>p</i> = 0.001). As an internal control, slices from vehicle-infused animals (black circles) show similar amounts of potentiation as those from Penetratin 1- conjugated Control siRNA treated animals. Error bars indicate SEM.</p
Dynamin inhibition by dynasore impairs associative memory.
<p><b>A</b>, Schematic representation of the hippocampi bilaterally implanted with cannulas. <b>B</b>, Bilateral injections of dynasore (80 μM in a final volume of 1.5 μl over 1 minute) into dorsal hippocampi, 20 minutes before training, dramatically impairs contextual fear memory (open bars) compared to vehicle treated mice (black bars) (Mann-Whitney U<sub>137, 73</sub> = 18.00, <i>p</i> = 0.00147). <b>C</b>, Mice do not show changes in cued fear conditioning following dynasore infusions (open bars) compared to vehicle-treated animals (black bars) (Mann-Whitney U<sub>121, 89</sub> = 34.00, <i>p</i> = 0.2412). Each bar represents the average percent of time spent in freezing posture. Error bars indicate SEM. <b>D</b>, Sensory threshold was not affected regardless of treatment (n = 10).</p